Home » Stocks » BICX

BioCorRx Inc. (BICX)

Stock Price: $4.99 USD 0.19 (3.96%)
Updated May 17, 2021 4:00 PM EDT - End of day
Market Cap 16.96M
Revenue (ttm) 122,621
Net Income (ttm) -3.47M
Shares Out 5.38M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 17
Last Price $4.99
Previous Close $4.80
Change ($) 0.19
Change (%) 3.96%
Day's Open 2.78
Day's Range 4.50 - 5.00
Day's Volume 1,564
52-Week Range 0.16 - 9.98

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ANAHEIM, CA, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --  BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substanc...

3 hours ago - GlobeNewsWire

ANAHEIM, CA, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc . (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of substan...

1 month ago - GlobeNewsWire

ANAHEIM, CA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorder...

1 month ago - GlobeNewsWire

ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorder...

2 months ago - GlobeNewsWire

ANAHEIM, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders...

4 months ago - GlobeNewsWire

About BICX

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The... [Read more...]

Industry
Medical Care Facilities
CEO
Brady Granier
Country
United States
Stock Exchange
OTCMKTS
Ticker Symbol
BICX
Full Company Profile

Financial Performance

In 2020, BioCorRx's revenue was $122,621, a decrease of -48.96% compared to the previous year's $240,259. Losses were -$3.47 million, -42.51% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for BioCorRx is 5.65, which is an increase of 13.23% from the latest price.

Price Target
$5.65
(13.23% upside)